Asthma-like syndrome in school children after accidental exposure to xylene and methylene diphenyl diisocyanate.
OBJECTIVE
We assessed the signs and symptoms, pulmonary function changes and residual chemical body burden of school children in the vicinity of an accidental exposure to volatile xylene and methylene diphenyl diisocyanate (MDI).


METHODS
After the exposure episode, children with significant symptoms after MDI exposure (e.g., dizziness, nausea, sore throat, and breathing difficulties) were sent to nearby emergency medical units for evaluation and admission if necessary. Clinical work-up included pulmonary function tests and measurement of residual MDI in the body by high-performance liquid chromatography analysis of urine.


RESULTS
203 students appeared to develop symptoms associated with contaminant exposure, and 173 affected students were sent to nearby emergency units. In the subsequent surveillance, 22 of 203 affected students (10.8%) revealed a positive history of asthma, which was strongly correlated with the incidence of dyspnea arising from the incident. For children with no previous history of asthma, 60.8% (110 of 181) complained of dyspnea during the episode, and 16.2% required inhaled bronchodilator therapy at the emergency medical units for relief of wheezing symptoms. In a simulation, we found the raw material used for tract surfacing, primarily MDI dissolved in xylene, to be present at a concentration (870 ppm w/w) more than 8000-fold the level defined as safe for a working environment.


CONCLUSIONS
We have detected a direct cause-effect relationship between the accidental spillage of MDI and the appearance of an acute asthma-like syndrome among previously unexposed school children.
Jan
Ren-Long
RL
Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Chen
Shin-Hong
SH
Chang
Ho-Yuan
HY
Yeh
Hui-Jung
HJ
Shieh
Chi-Chang
CC
Wang
Jiu-Yao
JY
D000293:Adolescent; D001249:Asthma / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D001944:Breath Tests; D016009:Chi-Square Distribution; D002648:Child; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D019570:Inhalation Exposure / Q000009:adverse effects*; D017953:Isocyanates / Q000378:metabolism / Q000633:toxicity* / Q000652:urine; D008297:Male; D012129:Respiratory Function Tests; D012574:Schools; D014992:Xylenes / Q000633:toxicity*; D001559:Benzhydryl Compounds
D017953:Isocyanates; D014992:Xylenes; C005969:4,4'-diphenylmethane diisocyanate; D001559:Benzhydryl Compounds